Telehealth giant Hims & Hers Health, Inc. (NYSE: HIMS) is celebrating a banner year, reporting a remarkable 69% surge in revenue for the full year 2025. The company's Q4 and full-year financial results, released on February 24th, 2026, showcase its ability to rapidly scale its personalized healthcare offerings and attract a growing base of loyal subscribers.

Impressive Growth Across the Board

Hims & Hers reported total revenue of $1.5 billion in 2024, up from $892 million the previous year. This impressive 69% year-over-year growth was fueled by a 45% increase in subscribers, which reached 2.2 million by the end of 2024. The company also achieved profitability, reporting net income of $126 million and adjusted EBITDA of $177 million for the full year.

"2024 was a fantastic year at Hims and Hers as we continue to build a platform that leverages personalization and technology unlike any traditional healthcare system," said Andrew Dudum, co-founder and CEO. "Over 2 million subscribers now entrust Hims & Hers to aid them in their journey to better health - with thousands more joining daily."

Ambitious Guidance for 2025

Looking ahead, Hims & Hers provided guidance for 2025 that calls for continued strong growth. The company expects revenue in the range of $2.3 billion to $2.4 billion, representing a 53-60% increase over 2024. Adjusted EBITDA is projected to be between $270 million and $320 million.

"In the coming years, we expect to further transform how individuals can improve their health with more comprehensive treatments, technologies that normalize unlimited follow up support, and tools that can eventually be exported beyond Hims and Hers, enabling even more Americans to access this care," Dudum added.

Telehealth Disrupting Traditional Healthcare

Hims & Hers' success is emblematic of the broader telehealth revolution that has been disrupting the traditional healthcare industry. As Reuters reports, telehealth visits in the U.S. nearly quadrupled in 2020 due to the COVID-19 pandemic. And according to WHO guidelines, digital health technologies like Hims & Hers' platform have the potential to improve access, quality, and affordability of healthcare worldwide.

The company's strong performance and ambitious plans for 2025 suggest Hims & Hers is well-positioned to capitalize on these trends and continue its rapid ascent. As recent analysis has shown, the future of healthcare is increasingly personalized, tech-enabled, and accessible - and Hims & Hers appears to be leading the charge.